XM does not provide services to residents of the United States of America.
C
C

ConvaTec


News

Bakkavor, Drax Group, Greggs

EUROPE RESEARCH ROUNDUP- Bakkavor, Drax Group, Greggs Aug 5 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Bakkavor, Drax Group and Greggs on Monday. HIGHLIGHTS * Bakkavor BAKK.L : HSBC raises target price to 170p from 150p * Drax Group Plc DRX.L : HSBC raises target price to 600p from 500p * Greggs GRG.L : HSBC cuts to hold from buy * Pennon Group PNN.L : Barclays cuts to equal-weight from overweight * United Utilities UU.L : Bar
A
B
B
B
B
B
B
C
C
C
C
C
D
D
E
E
G
H
I
R
S
A
A
A
B
D
E
P
U

British Business - Aug. 5

PRESS DIGEST-British Business - Aug. 5 Aug 5 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. The Times - Karim Bitar, the chief executive of Convatec CTEC.L has warned that the medical equipment maker's investment in the UK would be at risk if regulators do not approve a new wound care product stemming from its 45 million euro ($49.09 million) acquisition of the anti-infective
C

Bodycote, Croda, Spectris

EUROPE RESEARCH ROUNDUP- Bodycote, Croda, Spectris July 31 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Bodycote, Croda and Spectris, on Wednesday. HIGHLIGHTS * Bodycote Plc BOY.L : HSBC cuts target price to 940p from 950p * Bucher Industries AG BUCN.S : Berenberg cuts target price to CHF 464 from CHF 470 * Croda CRDA.L : HSBC cuts target price to 4400p from 4800p * Spectris Plc SXS.L : JP Morgan raises target price to 2,950p fr
A
A
A
B
B
B
C
C
C
C
D
D
E
E
G
G
H
I
L
S
S
S
A
D
F
I
I
P

UK's ConvaTec slips on profit miss; reiterates outlook

BUZZ-UK's ConvaTec slips on profit miss; reiterates outlook ** Shares of British medical equipment maker ConvaTec CTEC.L down 4.6% at 239.8 pence ** Stock is among top losers on the FTSE 100 index .FTSE ** Posts HY Adj operating profit of $222.8 mln which was a 4% miss according to JP Morgan ** Reiterates FY 2024 and medium-term outlook ** Includin
C
U

Convatec Group Confirms FY And Medium-Term Guidance

BRIEF-Convatec Group Confirms FY And Medium-Term Guidance July 30 (Reuters) - ConvaTec Group PLC CTEC.L : INTERIM RESULTS CONFIRMING FULL YEAR AND MEDIUM-TERM GUIDANCE Source text for Eikon: ID:nRSd2911Ya Further company coverage: CTEC.L
C

UK corporate earnings week ahead

DIARY-UK corporate earnings week ahead July 26 (Reuters) - Diary of U.K (.FTSE) corporate earnings for the week ahead UK EARNINGS Start Date Start Time (GMT) RIC Company Name Event Name 29-Jul-2024 BMO PSON.L Pearson PLC Half Year 2024 Pearson PLC Earnings Release 30-Jul-2024 22:30 RIO.L RIO.AX Rio Tinto PLC Rio Tinto Ltd Half Year 2024 Rio Tinto PLC Earnings Release 30-Jul-2024 NTS FRES.L Fresnillo PLC Half Year 2024 Fresnillo PLC Earnings Release 30-Jul-2024 NTS BP.L BP PLC Q2 2024 BP PLC Earn
B
B
C
C
F
H
I
M
P
S
S
S
W
R
R
T
U

Huhtamaki, Ryanair and Wizz Air

EUROPE RESEARCH ROUNDUP-Huhtamaki, Ryanair and Wizz Air June 21 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Huhtamaki, Ryanair and Wizz Air, on Friday. HIGHLIGHTS * B&M European Value Retail BMEB.L : Morgan Stanley cuts to underweight from equal weight * Huhtamaki HUH1V.HE : Barclays raises to overweight from equal-weight * Ryanair RYA.I : Barclays cuts to equal-weight from overweight * Wizz Air WIZZ.L : Barclays cuts to underw
A
A
A
A
A
B
B
B
B
B
C
C
E
F
G
I
L
L
M
N
N
O
P
S
S
T
T
V
A
R
R
S
U

AJ Bell, Kone Oyj, Wizz Air

EUROPE RESEARCH ROUNDUP-AJ Bell, Kone Oyj, Wizz Air May 24 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including AJ Bell, Kone Oyj and Wizz Air, on Friday. HIGHLIGHTS * AJ Bell AJBA.L : RBC raises target price to 380p from 320p * Greencore Group Plc GNC.L : Deutsche Bank raises target price to 130p from 105p * Kone Oyj KNEBV.HE : HSBC raises to buy from hold * Ocado OCDO.L : JP Morgan raises target price to 450p from 350p * Wizz Air WIZZ.
A
A
A
B
B
C
C
C
G
H
K
L
P
A
A
A
A
E
J

UK's ConvaTec falls after outlook cut in Advanced Wound Care segment

BUZZ-UK's ConvaTec falls after outlook cut in Advanced Wound Care segment ** ConvaTec Group's CTEC.L shares fall about 4.5% to 254.2 pence ** The British medical equipment maker says it is on track to deliver its FY24 guidance, even as outlook for the Advanced Wound Care segment - co's largest revenue generator - is reduced due to short-term uncert
C

Convatec Says Four Month Revenue Increased By 5.2% On A Reported Basis

BRIEF-Convatec Says Four Month Revenue Increased By 5.2% On A Reported Basis May 16 (Reuters) - ConvaTec Group PLC CTEC.L : CONVATEC GROUP PLC - FOR FOUR MONTHS, GROUP REVENUE INCREASED BY 5.2% ON A REPORTED BASIS CONVATEC GROUP - IN MEDIUM TERM, CONTINUES TO EXPECT TO DELIVER 5-7% ORGANIC REVENUE GROWTH ANNUALLY CONVATEC GROUP SEES TO EXPAND ADJUS
C



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.